As of 2024-07-27, the Relative Valuation of Biomarin Pharmaceutical Inc (BMRN) is 39.05 USD. This relative valuation is based on P/E multiples. With the latest stock price at 84.59 USD, the upside of Biomarin Pharmaceutical Inc based on Relative Valuation is -53.8%.
The range of the Relative Valuation is 34.21 - 49.94 USD.
| Range | Selected | |
| Trailing P/E multiples | 34.6x - 46.2x | 40.0x |
| Forward P/E multiples | 31.3x - 33.7x | 31.9x |
| Fair Price | 34.21 - 49.94 | 39.05 |
| Upside | -59.6% - -41.0% | -53.8% |
| Date | P/E |
| 2024-07-26 | 78.18 |
| 2024-07-25 | 79.11 |
| 2024-07-24 | 78.22 |
| 2024-07-23 | 78.04 |
| 2024-07-22 | 78.85 |
| 2024-07-19 | 77.72 |
| 2024-07-18 | 77.03 |
| 2024-07-17 | 78.25 |
| 2024-07-16 | 79.39 |
| 2024-07-15 | 78.18 |
| 2024-07-12 | 78.58 |
| 2024-07-11 | 77.56 |
| 2024-07-10 | 76.06 |
| 2024-07-09 | 76.70 |
| 2024-07-08 | 76.42 |
| 2024-07-05 | 75.28 |
| 2024-07-03 | 74.84 |
| 2024-07-02 | 75.99 |
| 2024-07-01 | 75.91 |
| 2024-06-28 | 76.10 |
| 2024-06-27 | 77.18 |
| 2024-06-26 | 78.79 |
| 2024-06-25 | 78.54 |
| 2024-06-24 | 78.69 |
| 2024-06-21 | 77.44 |
| 2024-06-20 | 78.30 |
| 2024-06-18 | 77.78 |
| 2024-06-17 | 78.58 |
| 2024-06-14 | 77.19 |
| 2024-06-13 | 77.86 |
| 2024-06-12 | 78.15 |
| 2024-06-11 | 77.52 |
| 2024-06-10 | 76.66 |
| 2024-06-07 | 74.58 |
| 2024-06-06 | 74.73 |
| 2024-06-05 | 73.64 |
| 2024-06-04 | 73.10 |
| 2024-06-03 | 70.62 |
| 2024-05-31 | 69.39 |
| 2024-05-30 | 68.84 |
| 2024-05-29 | 69.38 |
| 2024-05-28 | 68.79 |
| 2024-05-24 | 69.80 |
| 2024-05-23 | 70.15 |
| 2024-05-22 | 70.66 |
| 2024-05-21 | 71.48 |
| 2024-05-20 | 71.22 |
| 2024-05-17 | 71.69 |
| 2024-05-16 | 71.14 |
| 2024-05-15 | 74.31 |